Li2P INSERM UMR 1125
Physiopathologie, cibles et thérapies de la polyarthrite rhumatoïde
2011
Publications du Li2P INSERM UMR 1125
2011
Active immunization against IL-23p19 improves experimental arthritis.Ratsimandresy RA, Duvallet E, Assier E, Semerano L, Delavallée L, Bessis N, Zagury JF, Boissier MC Vaccine. 2011 Nov 21;29(50):9329-36
Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. Biton J, Semerano L, Delavallée L, Lemeiter D, Laborie M, Grouard-Vogel G, Boissier MC, Bessis N. J Immunol. 2011 Apr 1;186:3899-910.
Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis. Semerano L, Assier E, Delavallée L, Boissier MC. Expert Opin Biol Ther. 2011 Apr;11(4):545-50. Mar 9.
Neutrophils and interferon-a-producing cells: who produces interferon in lupus? Decker P. Arthritis Res Ther, 2011, 13:118-20.
A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis. Veenbergen S, Bennink MB, Affandi AJ, Bessis N, Biton J, Arntz OJ, van den Berg WB, van de Loo FA. Ann Rheum Dis. 2011 Dec;70(12):2167-75.
Interleukin-23: A key cytokine in inflammatory diseases. Duvallet E, Semerano L, Assier E, Falgarone G, Boissier MC. Ann Med. Ann Med. 2011 Nov;43(7):503-11.
Cell and cytokine imbalances in rheumatoid synovitis. Boissier MC. Joint Bone Spine. 2011 ;78:230-4.
Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus. Lindau D, Rönnefarth V, Erbacher A, Rammensee HG, Decker P. Eur J Immunol, 2011, 41:669-81.